Reinforcement Learning Drug Infusion Algorithm for Overdose Prevention

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Automated drug infusion systems face challenges in responding to sudden changes in patient state due to drug effect delays, leading to a risk of drug overinfusion, as existing algorithms fail to account for the unique pharmacological properties of each patient.

Innovation Solution

A method using reinforcement learning combined with pharmacokinetic-pharmacodynamic models to estimate patient-specific drug effects, allowing for continuous drug dose determination and automated infusion pump adjustments, incorporating a discount rate based on drug effects over time to prevent overinfusion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If automated infusion algorithms are used to reduce medical personnel workload, then productivity is improved, but reliability deteriorates due to drug overinfusion risk from time delay of effect

Engineering Contradiction:
Improvemedical personnel efficiencyVSAvoiddrug infusion safety
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements a closed-loop feedback system where the reinforcement learning algorithm continuously monitors patient state and drug effect, adjusting infusion rates in real-time based on observed outcomes. This feedback mechanism allows the system to learn from past infusion decisions and their delayed effects, improving safety while maintaining automation.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs preliminary actions by pre-training the reinforcement learning algorithm with simulated patient data and pharmacokinetic-pharmacodynamic models before actual deployment. This preliminary training enables the algorithm to anticipate drug effect delays and adjust infusion rates proactively, preventing overinfusion before it occurs.

Inventive Principle:
Principle #10Preliminary action

2Adaptability or versatility

If reinforcement learning algorithms are used to personalize drug dosing, then adaptability is improved, but device complexity increases due to integration of pharmacokinetic-pharmacodynamic models

Engineering Contradiction:
Improvepatient-specific dosing capabilityVSAvoidalgorithm integration complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent employs a universal reinforcement learning framework that can be applied across different patient populations and drug types by simply retraining with appropriate pharmacokinetic-pharmacodynamic models. This multi-functional approach allows the same core algorithm to serve multiple purposes, reducing overall system complexity while maintaining high adaptability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system achieves personalization by dynamically adjusting parameters within the reinforcement learning algorithm based on individual patient pharmacokinetic-pharmacodynamic characteristics. Rather than creating entirely separate algorithms for each patient, the system modifies key parameters such as reward functions and state transitions to account for individual variations, simplifying implementation while maintaining adaptability.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20220199217A1Method of determining continuous drug dose using reinforcement learning and pharmacokinetic-pharmacodynamic models
Publication Date: 2022.06.23 POSTECH ACADEMY INDUSTRY FOUNDATION
  • US20220199217A1 patent drawing
  • US20220199217A1 patent drawing
  • US20220199217A1 patent drawing

AI summary

A method of determining a continuous drug dose using reinforcement learning and a pharmacokinetic-pharmacodynamic model according to an embodiment of the present invention includes, measuring or estimating a patient's pharmacokinetic-pharmacodynamic model; training a reinforcement learning algorithm using drug infusion data and patient state data based on the pharmacokinetic-pharmacodynamic model; and automatically determining a continuous drug dose by the trained reinforcement learning algorithm.